Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:24:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T12:35:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice with NIH Clinical Center status and OPM updates appears at the top of the page, and the page revision is now v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T06:48:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary toggle, the Last Update Submitted that Met QC Criteria label, No FEAR Act Data text, and a Revision: v3.4.0 tag were added, while the older Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed. These changes are cosmetic and metadata-related and do not alter the study content.
    Difference
    0.1%
    Check dated 2026-01-28T04:48:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:31:45.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The study's Locations section was expanded and reorganized to include many additional sites across the US, Canada, Europe, Australia, and other regions. The previous grouped location entries (e.g., California Locations, District of Columbia Locations, etc.) have been removed or consolidated into a global list.
    Difference
    4%
    Check dated 2025-12-23T21:16:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.